Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
HOMSC-200 by Cytora for Diabetic Foot Ulcers: Likelihood of Approval
HOMSC-200 is under clinical development by Cytora and currently in Phase I for Diabetic Foot Ulcers. According to GlobalData, Phase...